Order of approximately SEK 66 million to a customer in the Educational Products business area

Surgical Science has, in its operations in the USA, received an order from a large American hospital chain for USD 6.7 million, corresponding to approximately SEK 65.9 million. The order is for a larger number of products, including simulators for training in endoscopy, laparoscopy and ultrasound.

The forecast is that the products will be delivered, and a majority of the revenues will be recognized, over the next six months.

"It is very gratifying to see one of the leading hospital chains in the United States invest so thoughtfully in increasing patient safety through simulation. We are proud to be able to offer this customer a complete portfolio of simulators for different specialties", says Gisli Hennermark, CEO of Surgical Science.

Gothenburg, Sweden, May 26, 2022
Surgical Science Sweden AB (publ)

The press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/aktien/pressmeddelanden/

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

For further information, please contact:

Gisli Hennermark, CEO
Telephone: +46-70-420 83 00
E-mail: gisli.hennermark@surgicalscience.com

Anna Ahlberg, CFO
Telephone: +46-70-855 38 35
E-mail: anna.ahlberg@surgicalscience.com

About Surgical Science Sweden AB (publ)

One of the biggest challenges within healthcare globally is how injuries during care can be reduced. Medical education and training are key, as a large part of the training today can be performed outside the operating room. Surgical Science is a world leader in the manufacture of virtual reality simulators for evidence-based training. The simulators enable surgeons and other medical specialists to train and improve their psychomotor skills and instrument handling before entering the clinical environment. In parallel with its own products, Surgical Science works with simulation solutions for medical technology companies that develop surgical instruments for clinical use, such as robotic surgery.

Surgical Science has more than 200 employees. The company is headquartered in Gothenburg, Sweden and also has operations in Stockholm, Sweden, as well as in Tel Aviv, Israel and Seattle, US. Through sales offices in the US, France and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Surgical Science Sweden AB (publ) is traded on Nasdaq First North Growth Market. Certified Adviser is Erik Penser Bank (Phone: +46 8-463 83 00; E-mail: certifiedadviser@penser.se).

This information is information that Surgical Science Sweden AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-05-26 17:25 CEST.

Attachments

Order of approximately SEK 66 million to a customer in the Educational Products business area

Order of approximately SEK 66 million to a customer in the Educational Products business area